Community-Based Interventions for Infant Health in Nepal

Child Mortality Clinical Trial

Official title:

An Evaluation of the Cost-Effectiveness of Community-Based Participatory Interventions for Pregnant Women in Nepal to Reduce Fetal and Infant Mortality, and to Improve Fetal Growth and Cognitive Development in Infancy.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00656591
• Other study ID #: 04PC01
• Status: Recruiting
• Phase: Phase 1
• First received: December 22, 2006
• Last updated: April 7, 2008
• Start date: March 2005
• Est. completion date: December 2008

Study information

• Verified date: April 2008
• Source: Institute of Child Health
• Contact: n/a
• Is FDA regulated: No
• Health authority: United Kingdom: National Health ServiceUnited Kingdom: Research Ethics Committee
• Study type: Observational

Clinical Trial Summary

An Evaluation of the Cost-Effectiveness of Community-Based Participatory Interventions for Pregnant Women in Nepal to Reduce Fetal & Infant Mortality and to Improve Fetal Growth & Cognitive Development in Infancy

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 192000
• Est. completion date: December 2008
• Est. primary completion date: December 2008
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• mothers, community health volunteers

Exclusion Criteria:

Study Design

Observational Model: Ecologic or Community, Time Perspective: Prospective

Related Conditions & MeSH terms

• Child Mortality

Intervention

Drug:
• Methotrexate
Methotrexate

Locations

Country	Name	City	State
United Kingdom	International Child Health, ICH	London

Sponsors (1)

Lead Sponsor	Collaborator
Institute of Child Health

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	neonatal mortality rates		2 years	No